Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/37/d8/7a/37d87ae2-af3e-0213-e439-57905d10d0b0/mza_13754466389719225512.jpg/600x600bb.jpg

Immuno Oncology Talks

Sanofi

11 episodes

7 months ago

In the current episode of “Immuno Oncology Talks”, we discuss the clinical challenges and future perspectives of CAR-T cells with our experts, from the Oslo University Hospital in Norway, Dr Else Marit Inderberg and Dr Sébastien Wälchli. Dr Inderberg is the head of the immunomonitoring at the hospital and has a research focus on novel immunotherapies, and Dr Wälchli is leading the CAR development platform. MAT-BE-2400334 (ver.1.0) 04 2024

Health & Fitness

Education

RSS

All content for Immuno Oncology Talks is the property of Sanofi and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Health & Fitness

Education

Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy

Immuno Oncology Talks

27 minutes

2 years ago

Tumor-Infiltrating Lymphocyte Based Adoptive Cellular Therapy

In the third episode of the “Immuno Oncology Talks”, we have had the pleasure to discuss tumor infiltrating lymphocytes for adoptive cell therapy with Professor Inge Marie Svane from the National Center for Cancer Immune Therapy in Denmark. Professor Inge Marie Svane has built up this centre into a leading European translational research centre. Apart from her vast expertise is T-cell based adoptive cell therapy, her research also focuses on other cellular therapies, cancer vaccines, and immu...